placeholder image
Dan J. Schneider, MD
Former Investigator, Metro-Minnesota Community Oncology Research Consortium
About

Affiliations/other offices held: Assistant professor, Department of Hematology, Oncology and Transplantation, University of Minnesota.

Education and training: MD, Southern Illinois University; fellowship in hematology and oncology, Loyola University, Chicago.

Overview/research interests: Dr. Schneider has been recognized for his leadership in the Minnesota Cooperative Group Outreach Program. While he is interested in all cancer treatment, he particularly enjoys approaching therapy through clinical trials, a mechanism to further improve our knowledge and success rates.

Publications While At 开云体育
selected publications
Journal Article
  • Nivolumab-induced posterior reversible encephalopathy syndrome
    Neurology. Clinical practice. 2017
  • North Central Cancer Treatment Group N0543 (Alliance): a phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma
    Cancer. 2017
  • Phase 1/2 dose escalating study of twice-monthly pemetrexed and gemcitabine in patients with advanced cancer and non-small cell lung cancer
    Journal of Thoracic Oncology. 2008
  • Conference Poster
  • Psychological and spiritual well being of breast cancer survivors in a community-based cancer survivorship clinic [poster]
    2010
  • Contact
    full name
  • Dan J. Schneider, MD
  • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration